Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update

R Granich, S Crowley, M Vitoria, C Smyth… - Current Opinion in …, 2010 - journals.lww.com
HAART has considerable treatment and prevention benefits and it needs to be considered
as a key element of combination prevention. To explore HAART as an effective prevention …

Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV

J Neuhaus, B Angus, JD Kowalska, A La Rosa… - Aids, 2010 - journals.lww.com
Objectives: Among patients with HIV, the risk of death associated with different AIDS events
has been quantified, but the risk of death associated with non-AIDS events has not been …

Continuous antiretroviral therapy decreases bone mineral density

B Grund, G Peng, CL Gibert, JF Hoy, RL Isaksson… - Aids, 2009 - journals.lww.com
Objectives: To assess the effects of antiretroviral therapy (ART) on bone mineral density
(BMD) Design: Randomized comparison of continuous ART (viral suppression group; VS) …

Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection

JV Baker, J Neuhaus, D Duprez, LH Kuller… - JAIDS Journal of …, 2011 - journals.lww.com
Objectives: Among a subgroup of participants in the Strategies for Management of
Antiretroviral Therapy (SMART) Trial that were naïve to antiretroviral therapy (ART) or off …

Risk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine care

RC Kalayjian, B Lau, RN Mechekano, HM Crane… - Aids, 2012 - journals.lww.com
Objective: To examine long-term effects of antiretroviral therapy (ART) on kidney function,
we evaluated the incidence and risk factors for chronic kidney disease (CKD) among ART …

The macrophage: the intersection between HIV infection and atherosclerosis

SM Crowe, CLV Westhorpe… - Journal of leukocyte …, 2010 - academic.oup.com
Review of the increased risk of coronary artery disease with HIV-1 infection, association with
traditional risk factors, monocyte activation, and impaired cholesterol metabolism. HIV …

Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters

HM Chun, MP Roediger, KH Hullsiek… - Journal of Infectious …, 2012 - academic.oup.com
Abstract (See the editorial commentary by Peters and Marston, on pages 166–8.)
Background. Understanding the impact of hepatitis B virus (HBV) in human …

Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy

MJ Mugavero, S Napravnik, SR Cole… - Clinical infectious …, 2011 - academic.oup.com
Background. Cross-sectional plasma human immunodeficiency virus (HIV) viral load (VL)
measures have proven invaluable for clinical and research purposes. However, cross …

HIV reactivation from latency after treatment interruption occurs on average every 5-8 days—implications for HIV remission

M Pinkevych, D Cromer, M Tolstrup, AJ Grimm… - PLoS …, 2015 - journals.plos.org
HIV infection can be effectively controlled by anti-retroviral therapy (ART) in most patients.
However therapy must be continued for life, because interruption of ART leads to rapid …

Use of antineoplastic agents in patients with cancer who have HIV/AIDS

MA Rudek, C Flexner, RF Ambinder - The lancet oncology, 2011 - thelancet.com
Highly active antiretroviral therapy (HAART) has substantially reduced morbidity and
mortality of AIDS-related complications in patients with HIV; however, the prevalence of …